Two Triad tech companies will get firsthand feedback from investors at the annual Nanotechnology Commercialization Conference in Durham April 4-5.
Salzburg Therapeutics and Orthovative Technologies will both take part in a “tough love” session with venture capitalists and angel investors during an invitation-only session.
Yadkinville-based Salzburg is developing cancer treatment drugs, while Orthovative has developed a patch that gives back-pain sufferers feedback to correct posture. Both companies have their roots at Wake Forest University. Read more.